𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Infliximab downregulates gelatinase B and tenascin in the mucosa of Crohn’s Disease patients

✍ Scribed by Karel Geboes; Paul Rutgeerts; Carrie Wagner; Allan Olson; Freddy Cornillie; Weihang Bao; Colleen Marano


Book ID
119393479
Publisher
Nature Publishing Group
Year
2002
Tongue
English
Weight
37 KB
Volume
97
Category
Article
ISSN
0002-9270

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Lamivudine resistance and exacerbation o
✍ Maria Esteve; Carme Loras; Ferran González-Huix 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB 👁 1 views

2004 we reported 3 cases of chronic hepatitis B in Crohn's disease (CD) patients from a cohort of 80 patients treated with infliximab. 1 Two patients showed severe reactivation, 1 of whom died. Based on the American Association for the Study of Liver Disease (AASLD) and European guidelines, 2,3 pree